St. Thomas and del Nido cardioplegia are superior to Custodiol cardioplegia in a rat model of donor heart.

Cardiac transplantation is an effective treatment for advanced heart disease and protection of the donor organ is directly associated with post-transplantation outcomes. Cardioplegic strategies intend to protect the donor heart against ischemic injury during transplantation procedures. In our study, the effects of three different cardioplegia solutions were evaluated in a rat heart donor model in terms of cellular base. Cardioplegia solutions as St. Thomas, del Nido or Custodiol were administered to male Wistar albino rats until cardiac arrest. Arrested hearts were excised and incubated in cold cardioplegia solutions for 4 h. Organ bath experiments were performed using the right ventricular free wall strips of the heart tissues. ATP, sialic acid, TNF-α levels and MMP-9 activities were measured in heart tissues. Incubation media were also used to measure TNF-α and troponin-I levels following organ baths experiments. Custodiol administration led to reduced myocardial contraction ( < .05), decreased ATP levels ( < .001) and increased both TNF-α levels ( < .05), and MMP-9 activity ( < .05). Additionally, troponin-I and TNF-α levels in media were significantly increased ( < .05), TNF-α levels were positively correlated with MMP-9 activities ( = .93,  = .007) and negatively correlated with ATP levels ( = -.91,  = .01) in the Custodiol group. Also, MMP-9 activities were negatively correlated with ATP levels ( = -.90,  = .01) Custodiol cardioplegia cannot prevent functional and cellular damage in donor heart tissue. St. Thomas or del Nido cardioplegia could result in superior functional and biochemical improvement during transplantation procedures. In this respect, these cardioplegic solutions may be more advantageous as cellular and functional.